RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
76 hedge funds and large institutions have $130M invested in Ra Pharmaceuticals, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
76
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$13.3M | |
| 2 | +$10.6M | |
| 3 | +$7.73M | |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$2.39M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.06M |
Top Sellers
| 1 | -$3M | |
| 2 | -$1.06M | |
| 3 | -$850K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$397K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$369K |